ProFunds Biotechnology UltraSector Fund

Scorecard
4 / 5 Stars
Lipper
5 3 1 5 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
C+ (Hold)

Fund Holdings

Asset Allocation

% Long % Net
Cash 42.2 42.2
Stocks 57.8 57.8
Bonds 0.0 0.0
Other 0.0 0.0
Foreign Bonds 0.0 0.0
Foreign Stocks 0.0 0.0
Convertible 0.0 0.0
Preferred 0.0 0.0

Updated 10.31.2013

Top 10 Holdings

Performance as of 03.31.2014

Portfolio as of 10.31.2013

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD -1.94 11.68
Amgen Inc AMGN 11.04 9.4
AbbVie Inc ABBV -0.59 8.26
Celgene Corporation CELG -13.24 6.56
Biogen Idec Inc BIIB 10.81 6.23
Alexion Pharmaceuticals, Inc. ALXN 16.9 2.58
Regeneron Pharmaceuticals, Inc. REGN 11.5 2.44
Vertex Pharmaceuticals VRTX -3.27 1.78
Life Technologies Corp LIFE 0.32 1.41
Illumina, Inc. ILMN 40.93 1.27